These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 11763343)
1. Neurovirulence of Sabin 1-derived polioviruses isolated from an immunodeficient patient with prolonged viral excretion. Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Nagata N; Kew O; Miyamura T Dev Biol (Basel); 2001; 105():93-8. PubMed ID: 11763343 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568 [TBL] [Abstract][Full Text] [Related]
3. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis. Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676 [TBL] [Abstract][Full Text] [Related]
5. Genomic characterization of type 1 Sabin-related polioviruses isolated in Brazil. Friedrich F; Filippis AM; Ferreira FC; Schatzmayr HG; Da Silva EE Acta Virol; 1995 Feb; 39(1):23-9. PubMed ID: 7572466 [TBL] [Abstract][Full Text] [Related]
6. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa. Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028 [TBL] [Abstract][Full Text] [Related]
7. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses. Otelea D; Guillot S; Furione M; Combiescu AA; Balanant J; Candrea A; Crainic R Dev Biol Stand; 1993; 78():33-8. PubMed ID: 8099049 [TBL] [Abstract][Full Text] [Related]
8. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model. Thorley B; Kelly H; Nishimura Y; Yoon YK; Brussen KA; Roberts J; Shimizu H J Clin Virol; 2009 Apr; 44(4):268-71. PubMed ID: 19269246 [TBL] [Abstract][Full Text] [Related]
9. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan. Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary. Kapusinszky B; Molnár Z; Szomor KN; Berencsi G FEMS Immunol Med Microbiol; 2010 Mar; 58(2):211-7. PubMed ID: 19863665 [TBL] [Abstract][Full Text] [Related]
11. Long-term excretion of vaccine-derived poliovirus by a healthy child. Martín J; Odoom K; Tuite G; Dunn G; Hopewell N; Cooper G; Fitzharris C; Butler K; Hall WW; Minor PD J Virol; 2004 Dec; 78(24):13839-47. PubMed ID: 15564492 [TBL] [Abstract][Full Text] [Related]
12. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082 [TBL] [Abstract][Full Text] [Related]
13. Oral poliovaccine: will it help eradicate polio or cause the next epidemic? Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa. Pavlov DN; Van Zyl WB; Van Heerden J; Grabow WO; Ehlers MM Water Res; 2005 Sep; 39(14):3309-19. PubMed ID: 15996707 [TBL] [Abstract][Full Text] [Related]
15. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients. Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922 [TBL] [Abstract][Full Text] [Related]
16. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees. Friedrich F Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097 [TBL] [Abstract][Full Text] [Related]
17. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis. Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521 [TBL] [Abstract][Full Text] [Related]
18. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine. Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835 [TBL] [Abstract][Full Text] [Related]
19. Succession of mutations in the Sabin strain of type 3 poliovirus replicating in the central nervous system of monkeys. Lu Z; Asher DM; Levenbook IS; Chumakov KM Virology; 1996 Jun; 220(2):285-9. PubMed ID: 8661379 [TBL] [Abstract][Full Text] [Related]
20. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions. Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]